Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polypodium leucotomos Extract for Prevention of Polymorphic Light Eruption
2006-000865-13Phase 3Completed
- Sponsor
- University Clinic of Dermatology
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Polypodium leucotomos in polymorphic light eruption (PMLE), sponsored by University Clinic of Dermatology. Primary endpoint: Primary prophylactic efficacy against PMLE. Started Mar 2006; status: completed.
02
Drugs
Polypodium leucotomos
03
Conditions
polymorphic light eruption (PMLE)
Beyond the preview
Go deeper on 2006-000865-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000865-13.